Premium Polysorb 013501LRecalls & reported problems
Covidien LP · Loading Unit with Polysorb Staples · Class 2 · Implant
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 10884521047570), received between May 4, 2021 and May 4, 2021 — classified as 1 injury.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
Patient problems
- Abscess1
- Fistula1
- Hemorrhage/Blood Loss/Bleeding1
- Post Operative Wound Infection1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
InjuryMay 4, 2021Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
ACCORDING TO THE LITERATURE, A STUDY PROSPECTIVELY ANALYZED 150 PATIENTS WHO UNDERWENT DISTAL PANCREATECTOMY IN THE LAST 20 YEARS. AN AUTO SUTURE STAPLER WAS USED TO LIGATE THE SPLENIC ARTERY AND VEIN IN PATIENTS WHO UNDERWENT SPLENECTOMY. THE DEVICE WAS USED TO AMPUTATE THE PANCREAS AND TWO STAPLES WERE LEFT IN THE PROXIMAL PANCREATIC STUMP. THE AVERAGE DURATION OF THE OPERATION WAS 150 MIN (RANGE: 90-210 MIN) AND NO TRANSFUSION WAS INDICATED DURING THE OPERATION. IF BLEEDING WAS OBSERVED, ANOTHER MANUFACTURE¿S SUTURE WAS USED TO OVERSEW THE AREA OF BLEEDING. NOTED MORBIDITY ON 5 PATIENTS, BUT NO MORTALITY OCCURRED IN THE POSTOPERATIVE PERIOD. OVERALL, THE POSTOPERATIVE PERIOD WAS UNEVENTFUL WITHOUT ANY COMPLICATIONS (PANCREATIC FISTULA, ABSCESS, BLEEDING OR WOUND INFECTION) IN 145 PATIENTS. IT WAS STATED THAT ONE POST-OPERATIVE PANCREATIC FISTULA WHICH WAS TREATED WITH MEDICATION AND JEJUNAL FEEDING. TWO PATIENTS SUFFERED PANCREATITIS AND REOPERATION DUE TO BLEEDING. REOPERATIONS WERE PERFORMED ON TWO PATIENTS ON THE FIRST OR SECOND POSTOPERATIVE DAY, NECESSITATED BY BLEEDING FROM THE RETROPERITONEAL REGION. HOSPITALIZATION WAS EXTENDED FOR PATIENTS WITH POST-OPERATIVE COMPLICATI
Patient problems: Abscess; Fistula; Hemorrhage/Blood Loss/Bleeding; Post Operative Wound Infection
MAUDE report 11769832 ↗
Other STAPLE, IMPLANTABLE devices
- Endo GIA EGIA60AMTCovidien LP · STAPLE, IMPLANTABLE19 deaths10,680 reports
- Endo GIA Ultra EGIAUSTNDCovidien LP · STAPLE, IMPLANTABLE5 deaths9,730 reports
- Signia SIGPHANDLECovidien LP · STAPLE, IMPLANTABLE1 recall3 deaths5,356 reports
- ECHELON FLEX PSEE60AEthicon Endo-Surgery, LLC · STAPLE, IMPLANTABLE1 recall13 deaths3,294 reports
- Endo GIA Ultra EGIAUSHORTCovidien LP · STAPLE, IMPLANTABLE2 deaths3,011 reports
- Endo GIA EGIA45AMTCovidien LP · STAPLE, IMPLANTABLE10 deaths2,965 reports
- Endo GIA Ultra EGIAUXLCovidien LP · STAPLE, IMPLANTABLE2,909 reports
- ENDOPATH ATS45Ethicon Endo-Surgery, LLC · STAPLE, IMPLANTABLE2 deaths2,046 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page